Intravitreal Bevacizumab for Neovascular Glaucoma

200989 citationsJournal Article

Authors

Mehdi Yaseri · Tehran University of Medical Sciences

Abstract

Intravitreal injections of bevacizumab seem to reduce NVI and IOP in NVG and may be considered as an adjunct to more definitive surgical procedures for NVG.

Topics & Keywords

Retinal Diseases and Treatments Retinal and Macular Surgery Glaucoma and retinal disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Glaucoma

Volume 18, Issue 8, pp. 632-637

DOI: 10.1097/ijg.0b013e3181997211

Field-Weighted Citation Impact: 4.30